Male-female differences in contemporary elective ascending aortic surgery: insights from the Netherlands Heart Registration
Introduction
The exact incidence of thoracic aortic aneurysm (TAA) remains uncertain because of its asymptomatic character but is estimated to be 6–10 per 100,000 person years (1,2). The death rate due to aortic aneurysm in Western Europe in 2010 was estimated to be 7.68 per 100,000 (3). As a result of improved diagnosis, monitoring and treatment options, morbidity and mortality have improved in recent years (4). While there has been a lot of attention to male-female differences in diagnosis and surgical treatment of coronary artery disease, little is known about potential male-female differences in presentation, treatment and outcomes in TAA and current guidelines acknowledge the lack of male-female specific literature regarding aortic disease (5). The scarcely available published evidence, often single center with a limited sample size, provides contradicting insights (6-8).
Knowledge of the differences between men and women in determinants of outcome is important to provide patient-tailored treatment decision-making. With this knowledge, hopefully, outcomes in both men and women can be improved. Therefore, the aim of this study was to identify male-female differences in diagnosis, treatment and in-hospital mortality and morbidity in contemporary [2013–2017] elective ascending aortic aneurysm surgery, using data from the Netherlands Heart Registration.
Methods
Study design and patient selection
A retrospective analysis of data from the Netherlands Heart Registration (NHR) was performed. The NHR is a Dutch nationwide prospective registry that contains anonymized peri-operative patient data of all cardiothoracic surgical procedures and percutaneous cardiac interventions performed in the Netherlands. Approval from the board of the NHR was obtained on 18-01-2019 to analyze the requested dataset. The study was reported following the STROBE statement (9).
The NHR database was queried for all adult patients (≥18 years) undergoing thoracic aortic surgery between 01-01-2013 and 31-12-2017, totaling 6,114 procedures. Exclusion criteria were isolated descending aortic surgery or isolated thoracic endovascular aortic repair (N=536 and N=14 respectively), isolated aortic arch surgery (N=85), no aortic surgery performed or type of surgery could not be determined (N=15 and N=14 respectively), cardiac transplant (N=1), duplicate patient (N=2), and non-elective surgery (urgent N=685, emergency/salvage N=1,133, missing N=770). A total of 2,859 patients undergoing elective ascending aortic surgery, with or without concomitant cardiac or aortic surgery, were included.
Endpoints and definitions
The primary endpoint of this study was in hospital mortality stratified by sex. Secondary endpoints were patient characteristics, procedural characteristics, in-hospital morbidity, and risk factors for in-hospital mortality stratified by sex.
Statistical analysis
Descriptive statistical analyses
Normally distributed continuous variables were presented as mean ± standard deviation and compared using the Student’s t-test. Skewed continuous variables were presented as median and interquartile range and compared using the Mann-Whitney U test. Normality of the distributions was tested using the Kolmogorov-Smirnov test. Categorical variables were presented as counts and percentages and compared using the χ2-test or the Fisher’s exact test, as appropriate. The descriptive statistical analyses were performed on the original dataset.
Imputation of missing values
An imputed dataset was used for the exploration of risk factors for in-hospital mortality, using multivariable logistic regression modelling. The missing values were presented in Table S1. Missing values were assumed to be missing at random: inspection of missing data pattern plots was performed, and for variables with >5% missing associations between the missing values and the other variables eligible for the logistic regression analyses were investigated by student’s t-tests and cross tabulation inspection. Assuming missing at random, multiple imputation was performed to impute missing covariate values for the logistic regression analyses (10). Covariates exceeding 15% missing values were omitted from imputation and the logistic regression analysis. To prevent the induction of bias, we excluded for imputation those variables that are present after a treatment decision is made (e.g., procedural characteristics). The imputed variables were: age, sex, body mass index (BMI), creatinine level, left ventricular ejection fraction (LVEF) (categorized), chronic pulmonary disease, arterial pathology, prior cardiac or aortic surgery, neurological dysfunction, active endocarditis, recent myocardial infarction, prior percutaneous coronary intervention (PCI), pulmonary artery pressure and diabetes. Five imputed datasets were generated using 5 iterations each. The imputations were visually checked by strip plots and density plots.
Logistic regression analyses
The imputed datasets were used to develop the multivariable logistic regression models. Preoperative and procedural variables were eligible as covariates if they did not exceed 15% missing values, and if there were at least 10 events due to in-hospital mortality (for categorical variables: at least 10 events per category). Correlations between covariates were checked using Pearson and Spearman correlation coefficients, as appropriate. In the case of high correlation (between ±0.50 and ±1.0) the clinically most relevant variable was chosen. Variables with a P value <0.1 in univariate modelling were selected for inclusion in the multivariable model. A full multivariable model was chosen to be presented. The analyses were performed on all five imputed datasets and the results were aggregated using Rubin’s rules for multiple imputation (11). Odds ratios (ORs) with corresponding 95% confidence intervals (95% CIs) were reported.
To further explore male-female differences in risk factors for in-hospital mortality, multivariable logistic regression models for the male and female subpopulation were developed. These models were developed to explore male-female differences in both the independent risk factors, as well as in the weight of these risk factors for in-hospital mortality. For these models subsets of the imputed datasets were used: one subset was created of the female population and one subset of the male population. These subsets of the imputed datasets were then used to develop multivariable logistic regression models, as described above for the complete study population: preoperative and procedural variables were eligible as covariates if they did not exceed 15% missing values, if there were at least 10 events due to in-hospital mortality, and in the case of highly correlated covariates the clinically most relevant variable was chosen. Variables with a P value <0.1 in univariate modelling were selected for inclusion in the multivariable model, and a full multivariable model was presented. The analyses were performed on all five imputed datasets and the results were aggregated. ORs with corresponding 95% CIs were reported. Figures S1-S5 show missing data pattern plots and imputed data plots for the variables that were used in the multivariable logistic regression model.
All statistical analyses were performed in computing and statistical program R (The R foundation for Statistical Computing, Vienna, Austria. Version 3.6.1.) using packages “glm” and “MICE”. A P value <0.05 was considered significant for all statistical tests.
Results
Patient characteristics
Table 1 displays preoperative patient characteristics for the entire cohort, and the female and male subcohorts. Females presented at an older age [median 67 (IQR, 59–73) versus median 62 (IQR, 53–70) years old, P<0.001], with a higher EuroSCORE [median 14.7 (IQR, 9.4–21.7) versus median 8.8 (IQR, 4.8–14.5), P<0.001], with more often chronic pulmonary disease (12.3% versus 9.1%, P=0.011), and a higher New York Heart Association (NYHA) class (class III–IV 21.5% versus 15.5%, P=0.003) compared to males. Males presented with a higher BMI [median 26.3 (IQR, 24.3–29.0) versus median 25.7 (IQR, 22.8–29.0), P<0.001] and creatinine level [median 88 (IQR, 79–100) versus median 72 (IQR, 63–83), P<0.001].
Table 1
Patient characteristic | Overall (N=2,859) | Female (N=887, 31%) | Male (N=1,972, 69%) | P value |
---|---|---|---|---|
Age | 64 [54–71] | 67 [59–73] | 62 [53–70] | <0.001 |
Body mass index (kg/m2) | 26.1 [23.9–29.0] | 25.7 [22.8–29.0] | 26.3 [24.3–29.0] | <0.001 |
Creatinine level (μmol/L) | 84 [73–97] | 72 [63–83] | 88 [79–100] | <0.001 |
Creatinine (>200 μmol/L) | 25 (0.9) | 4 (0.5) | 21 (1.1) | 0.129 |
Logistic EuroSCORE | 10.6 [6.4–17.2] | 14.7 [9.4–21.7] | 8.8 [4.8–14.5] | <0.001 |
Diabetes mellitus | 189 (6.8) | 60 (7.0) | 129 (6.7) | 0.807 |
LVEF | 0.205 | |||
LVEF <30% | 62 (2.2) | 13 (1.5) | 49 (2.5) | |
LVEF 30–55% | 2,052 (72.3) | 638 (72.3) | 1,414 (72.3) | |
LVEF >55% | 725 (25.5) | 231 (26.2) | 494 (25.2) | |
Chronic pulmonary disease | 289 (10.1) | 109 (12.3) | 180 (9.1) | 0.011 |
Chronic arterial pathology | 274 (9.6) | 94 (10.6) | 180 (9.1) | 0.216 |
Neurological dysfunction | 63 (2.2) | 17 (1.9) | 46 (2.3) | 0.582 |
Active endocarditis | 41 (1.4) | 7 (0.8) | 34 (1.7) | 0.082 |
Recent myocardial infarction | 34 (1.2) | 7 (0.8) | 27 (1.4) | 0.061 |
PA pressure (mmHg) | 25 [25–25] | 25 [25–25] | 25 [25–25] | 0.812 |
Prior CVA | 89 (4.6) | 20 (3.3) | 69 (5.1) | 0.099 |
Dialysis | 6 (0.3) | 2 (0.3) | 4 (0.3) | >0.99 |
NYHA class | 0.003 | |||
I–II | 1,471 (82.7) | 421 (78.5) | 1,050 (84.5) | |
III–IV | 307 (17.3) | 115 (21.5) | 192 (15.5) | |
CCS class IV | 18 (0.9) | 3 (0.5) | 15 (1.0) | 0.303 |
Prior PCI | 118 (4.4) | 26 (3.2) | 92 (5.0) | 0.033 |
Prior aortic surgery | 246 (10.0) | 80 (10.4) | 166 (9.8) | 0.663 |
Prior cardiac surgery | 502 (17.6) | 153 (17.3) | 349 (17.7) | 0.832 |
Continuous variables presented as median with interquartile range, and categorical variables presented as counts with percentages. LVEF, left ventricular ejection fraction; PA, pulmonary artery; CVA, cerebrovascular accident; CCS, Canadian Cardiovascular Society; NYHA, New York Heart Association; PCI, percutaneous coronary intervention.
Procedural characteristics
Table 2 displays procedural characteristics for the entire cohort, and the female and male subcohorts. Female patients underwent supracoronary ascendens replacement significantly more often (47.7% versus 30.6%, P<0.001), whereas male patients underwent aortic root and aorta ascendens replacement significantly more often (56.7% versus 40.6%, P<0.001). Female patients received concomitant aortic arch surgery (33.1% versus 20.2%, P<0.001) and mitral valve surgery (8.2% versus 5.2%, P=0.002) significantly more often, whereas male patients received concomitant coronary artery bypass grafting (CABG) significantly more often (19.1% versus 14.4%, P=0.002).
Table 2
Patient characteristic | Overall (N=2,859) | Female (N=887, 31%) | Male (N=1,972, 69%) | P value |
---|---|---|---|---|
Surgery type | <0.001 | |||
Aortic root and ascendens replacement | 1,479 (51.7) | 360 (40.6) | 1,119 (56.7) | |
Supracoronary ascendens replacement | 1,027 (35.9) | 423 (47.7) | 604 (30.6) | |
Ascendens replacement (location unknown) | 353 (12.3) | 104 (11.7) | 249 (12.6) | |
Aortic root and ascendens replacement | 1,479 (51.7) | 360 (40.6) | 1,119 (56.7) | <0.001 |
Without valve intervention | 146 (5.1) | 34 (3.8) | 112 (5.7) | |
With biological prosthesis | 650 (22.7) | 190 (21.4) | 460 (23.3) | |
With mechanical prosthesis | 488 (17.1) | 94 (10.6) | 394 (20.0) | |
With homograft | 10 (0.3) | 4 (0.5) | 6 (0.3) | |
With autograft | 7 (0.2) | 4 (0.5) | 3 (0.2) | |
Valve-sparing root replacement | 178 (6.2) | 34 (3.8) | 144 (7.3) | |
Supracoronary ascendens replacement | 1,027 (35.9) | 423 (47.7) | 604 (30.6) | <0.001 |
Without valve intervention | 481 (16.8) | 236 (26.6) | 245 (12.4) | |
With aortic valve plasty | 56 (2.0) | 26 (2.9) | 30 (1.5) | |
With biological prosthesis | 344 (12.0) | 122 (13.8) | 222 (11.3) | |
With mechanical prosthesis | 145 (5.1) | 38 (4.3) | 107 (5.4) | |
With homograft | 1 (0.0) | 1 (0.1) | 0 (0.0) | |
Ascendens replacement (location unknown)* | 353 (12.3) | 104 (11.7) | 249 (12.6) | 0.001 |
Without valve intervention | 37 (1.3) | 12 (1.4) | 25 (1.3) | |
With aortic valve plasty | 35 (1.2) | 19 (2.1) | 16 (0.8) | |
With biological prosthesis | 183 (6.4) | 56 (6.3) | 127 (6.4) | |
With mechanical prosthesis | 80 (2.8) | 12 (1.4) | 68 (3.4) | |
With homograft | 1 (0.0) | 0 (0.0) | 1 (0.1) | |
With valve replacement, type unknown | 17 (0.6) | 5 (0.6) | 12 (0.6) | |
Concomitant arch surgery | 692 (24.2) | 293 (33.1) | 399 (20.2) | <0.001 |
Concomitant descending aortic surgery | 77 (2.7) | 31 (3.5) | 46 (2.3) | 0.081 |
Concomitant CABG | 505 (17.7) | 128 (14.4) | 377 (19.1) | 0.002 |
Concomitant mitral valve surgery | 176 (6.2) | 73 (8.2) | 103 (5.2) | 0.002 |
Concomitant pulmonary valve surgery | 13 (0.5) | 4 (0.5) | 9 (0.5) | 1.000 |
Concomitant tricuspid valve surgery | 59 (2.1) | 25 (2.8) | 34 (1.7) | 0.064 |
Other concomitant surgery | 209 (7.3) | 87 (9.8) | 122 (6.2) | 0.001 |
Circulatory arrest performed | 766 (26.8) | 320 (36.2) | 446 (22.6) | <0.001 |
Continuous variables presented as median with interquartile range, and categorical variables presented as counts with percentages. *, in the database it was unknown which parts of the ascending aorta were replaced exactly. CABG, coronary artery bypass grafting. CPB, cardiopulmonary bypass.
In-hospital mortality and morbidity
Table 3 displays postoperative in-hospital mortality and morbidity. In-hospital mortality was significantly higher in female patients (5.1% versus 2.7%, P=0.003). Furthermore, female patients had a longer admission duration [median days 8 (IQR, 6–12) versus median days 7 (IQR, 5–10), P<0.001], more often had extended intubation (>24 hours, 7.7% versus 4.9%, P=0.004), and more often had urinary tract infections (3.2% versus 1.2%, P<0.001).
Table 3
Outcome variable | Overall (N=2,859) | Female (N=887, 31%) | Male (N=1,972, 69%) | P value |
---|---|---|---|---|
In-hospital mortality | 99 (3.5) | 45 (5.1) | 54 (2.7) | 0.003 |
Admission in days | 7 [5–11] | 8 [6–12] | 7 [5–10] | <0.001 |
Perioperative myocardial infarction | 0.475 | |||
One criterion | 86 (4.6) | 21 (3.7) | 65 (5.0) | |
Two or more criteria | 34 (1.8) | 11 (1.9) | 23 (1.8) | |
Pneumonia | 131 (5.2) | 31 (4.0) | 100 (5.8) | 0.065 |
Urinary tract infection | 46 (1.8) | 25 (3.2) | 21 (1.2) | <0.001 |
Reintubation during admission | 83 (3.3) | 34 (4.3) | 49 (2.8) | 0.070 |
Extended intubation (exceeding 24 hours) | 165 (5.8) | 68 (7.7) | 97 (4.9) | 0.004 |
Readmission to ICU | 135 (4.8) | 49 (5.6) | 86 (4.4) | 0.183 |
CVA with permanent damage | 68 (2.4) | 27 (3.1) | 41 (2.1) | 0.143 |
CVA without permanent damage | 20 (0.8) | 9 (1.2) | 11 (0.6) | 0.225 |
Renal failure | 79 (2.8) | 26 (3.0) | 53 (2.7) | 0.712 |
Gastrointestinal complications | 0.832 | |||
Unknown | 2 (0.1) | 0 (0.0) | 2 (0.1) | |
Yes, type unknown | 4 (0.1) | 1 (0.1) | 3 (0.2) | |
Bleeding | 11 (0.4) | 4 (0.5) | 7 (0.4) | |
Yes, other | 23 (0.8) | 9 (1.0) | 14 (0.7) | |
Vascular complications | 18 (0.6) | 6 (0.7) | 12 (0.6) | 0.802 |
Heart rhythm complications | 964 (34.8) | 313 (36.3) | 651 (34.1) | 0.282 |
Rethoracotomy | 0.805 | |||
Bleeding/tamponade | 203 (10.7) | 57 (9.7) | 146 (11.2) | |
Cardiac | 37 (2.0) | 12 (2.0) | 25 (1.9) | |
Other | 8 (0.4) | 2 (0.3) | 6 (0.5) | |
Deep sternal wound infection | 7 (0.4) | 1 (0.2) | 6 (0.5) | 0.445 |
Continuous variables presented as median with interquartile range, and categorical variables presented as counts with percentages. ICU, intensive care unit; CVA, cerebrovascular accident.
Risk factors in-hospital mortality
Table 4 shows the uni- and multi-variable risk factor analysis for in-hospital mortality for the entire study population. Independent risk factors for in-hospital mortality were: older age (OR 1.04, 95% CI: 1.02–1.06), being female (OR 1.55, 95% CI: 1.02–2.37), chronic lung disease (OR 2.65, 95% CI: 1.64–4.30), previous cardiac or aortic surgery (OR 2.05, 95% CI: 1.25–3.35), and concomitant CABG and/or valve surgery (other than the aortic valve) (OR 2.82, 95% CI: 1.85–4.31).
Table 4
Risk factors | Entire study population | ||||
---|---|---|---|---|---|
Univariate | Multivariable | ||||
Odds ratio (95% CI) | P value | Odds ratio (95% CI) | P value | ||
Age (years) | 1.05 (1.03–1.07) | <0.001 | 1.04 (1.02–1.06) | 0.001 | |
Female | 1.90 (1.27–2.83) | 0.002 | 1.55 (1.02–2.37) | 0.041 | |
Body mass index (kg/m2) | 0.99 (0.94–1.04) | 0.656 | |||
Creatinine (µmol/L) | 1.00 (1.00–1.01) | 0.263 | |||
Left ventricular ejection fraction 30–55%* | 1.22 (0.75–1.99) | 0.427 | 1.18 (0.71–1.97) | 0.530 | |
Left ventricular ejection fraction <30%* | 2.92 (1.06–8.00) | 0.039 | 2.51 (0.87–7.21) | 0.089 | |
Chronic lung disease | 3.56 (2.25–5.64) | <0.001 | 2.65 (1.64–4.30) | <0.001 | |
Arterial pathology | 2.48 (1.51–4.14) | <0.001 | 1.51 (0.88–2.59) | 0.135 | |
Previous cardiac or aortic surgery | 1.73 (1.12–2.72) | 0.021 | 2.05 (1.25–3.35) | 0.005 | |
Aortic root replacement** | 0.79 (0.51–1.25) | 0.317 | |||
Aortic ascendens replacement, location unspecified** | 1.32 (0.73–2.36) | 0.357 | |||
Concomitant aortic arch surgery | 1.84 (1.21–2.77) | 0.005 | 1.53 (0.98–2.40) | 0.061 | |
Concomitant CABG and/or valve surgery (other than aortic valve) | 3.35 (2.23–5.00) | <0.001 | 2.82 (1.85–4.31) | <0.001 |
*, reference category is left ventricular ejection fraction >55%; **, reference category is supracoronary replacement. CABG, coronary artery bypass surgery.
Table 5 shows the uni- and multi-variable risk factor analysis for in-hospital mortality for the female and male subpopulations. For the female subpopulation, chronic lung disease (OR 3.00, 95% CI: 1.51–5.99) and concomitant CABG and/or valve surgery (other than the aortic valve) (OR 3.74, 95% CI: 1.97–7.10) were independent risk factors. For the male subpopulation, older age (OR 1.04, 95% CI: 1.01–1.07), chronic lung disease (OR 2.10, 95% CI: 1.05–4.18), arterial pathology (OR 2.34, 95% CI: 1.20–4.57), concomitant aortic arch surgery (OR 2.01, 95% CI: 1.08–3.71) and concomitant CABG and/or valve surgery (other than the aortic valve) (OR 2.08, 95% CI: 1.17–3.67) were independent risk factors.
Table 5
Risk factors | Female population | Male population | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariable | Univariate | Multivariable | ||||||||
Odds ratio (95% CI) |
P value | Odds ratio (95% CI) |
P value | Odds ratio (95% CI) |
P value | Odds ratio (95% CI) |
P value | ||||
Age (years) | 1.04 (1.00–1.07) | 0.023 | 1.03 (1.00–1.06) | 0.096 | 1.06 (1.03–1.09) | <0.001 | 1.04 (1.01–1.07) | 0.005 | |||
Body mass index (kg/m2) | 1.01 (0.96–1.07) | 0.619 | 0.96 (0.90–1.03) | 0.328 | |||||||
Creatinine (µmol/L) | 1.01 (1.00–1.01) | 0.094 | 1.01 (1.00–1.01) | 0.103 | 1.00 (1.00–1.01) | 0.347 | |||||
Left ventricular ejection fraction 30–55%* | 1.39 (0.66–2.94) | 0.389 | 1.38 (0.64–2.97) | 0.418 | 1.12 (0.58–2.14) | 0.748 | |||||
Left ventricular ejection fraction <30%* | 4.53 (0.87–23.57) | 0.073 | 2.72 (0.46–16.12) | 0.272 | 2.59 (0.70–9.39) | 0.154 | |||||
Chronic lung disease | 3.97 (2.05–7.61) | <0.001 | 3.00 (1.51–5.99) | 0.002 | 2.97 (1.54–5.75) | 0.001 | 2.10 (1.05–4.18) | 0.035 | |||
Arterial pathology | 1.31 (0.54–3.19) | 0.553 | 3.71 (1.97–6.96) | <0.001 | 2.34 (1.20–4.57) | 0.013 | |||||
Previous cardiac or aortic surgery | 1.80 (0.92–3.53) | 0.104 | 1.68 (0.91–3.10) | 0.101 | |||||||
Aortic root replacement** | 1.46 (0.77–2.77) | 0.242 | 0.58 (0.32–1.08) | 0.088 | 0.93 (0.49–1.79) | 0.840 | |||||
Ascending aorta replacement, location unspecified** | 1.14 (0.41–3.13) | 0.805 | 1.48 (0.71–3.06) | 0.295 | 1.99 (0.90–4.35) | 0.086 | |||||
Concomitant aortic arch surgery | 1.25 (0.67–2.32) | 0.492 | 2.20 (1.25–3.90) | 0.007 | 2.01 (1.08–3.71) | 0.027 | |||||
Concomitant CABG and/or valve surgery (other than aortic valve) | 4.76 (2.59–8.76) | <0.001 | 3.74 (1.97–7.10) | <0.001 | 2.61 (1.51–4.48) | <0.001 | 2.08 (1.17–3.67) | 0.012 |
*, reference category is left ventricular ejection fraction >55%; **, reference category is supracoronary replacement. CABG, coronary artery bypass surgery.
Discussion
This nation-wide cohort shows clear male-female differences in patient presentation, procedural characteristics, in-hospital mortality and morbidity, and risk factors for in-hospital mortality in contemporary elective ascending aortic surgery in The Netherlands.
Patient and procedural characteristics
Patient characteristics were significantly different between male and female patients, including known risk factors for cardiovascular surgery. It is obvious from the observed differences in patient characteristics that female patients are older, tend to present in a worse clinical condition with a higher NYHA class and more often chronic pulmonary disease, while male patients more often had a previous percutaneous coronary intervention (PCI). These differences are also reflected in the higher logistic EuroSCORE found in female patients.
The older age at the time of surgery has been found in previous studies (6,7,12) and can be attributed to biological factors, such as the protective effect of estrogen on cardiovascular diseases, causing a delayed aortic aneurysm incidence in female patients (13). However, socio-cultural factors related to gender such as a delayed presentation due to patient and/or physician delay may also be a contributing factor, and remains to be explored as no evidence in the context of TAA surgery is available in this regard. However, a delayed recognition by physicians in female patients has been observed in aortic dissection (14).
In the current study, aortic diameter at surgery was not available. However, as the study comprised elective surgical patients, we can assume the 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases were followed regarding timing of surgery (5). However, in published literature, it has been shown that female patients undergo surgery at a larger body size indexed aortic diameter than male patients (7), and aortic dilatation rates in female patients are higher (15), both of which are risk factors for aortic dissection. Furthermore, population-based studies show that female patients have higher out of hospital deaths caused by acute aortic dissection than male patients (16,17). Considering the above, it is possible worse outcomes due to aortic disease in female patients unfortunately remain undocumented. In the light of elective surgery, it is important to be aware of these differences, to prevent dissections through timely interventions.
The differences observed in the procedural characteristics might indicate different underlying pathophysiology of aneurysm development, as male patients more often underwent a procedure including the root, whereas female patients more often underwent a procedure without root replacement and with arch replacement. Sokolis et al. found differences between male and female patients in ascending TAAs in mechanics and matrix, which supports the possibility of different underlying pathophysiology (18). Furthermore, male patients more often underwent concomitant CABG surgery which indicates more atherosclerotic disease in male patients, as observed by previous studies (6,12).
Mortality and morbidity
We observed a higher unadjusted in-hospital mortality in female patients. Published literature on ascending aortic surgery shows contradicting estimates of male-female post-operative mortality differences (6-8,12,19). However, these studies are usually single center with a limited sample size and concern diverging patient populations, for example including emergency surgery (7,8,19), or focusing on a specific surgical technique (12). Beller et al. found a comparable short-term mortality between male and female patients undergoing elective ascending aortic aneurysm surgery, whereas Chung et al. found a higher mortality in female patients undergoing thoracic aortic surgery with deep hypothermic circulatory arrest (6,19). Beller and colleagues had a comparable population to ours, and although they did not find a significant difference in 30-day mortality, they had a smaller population, a smaller number of events, and there was a trend towards a significant difference (30-day mortality rate in males of 3.5%, in females 7.9%, P value of 0.058) (6).
Female patients experienced more morbidity post-surgery: a longer admission time, more often extended intubation, and more urinary tract infections. Other adverse in-hospital outcomes were comparable. Awareness of the differences is important, in order to take preventative measures wherever possible (e.g., removing bladder catheters as soon as possible).
Risk factor differences between male and female patients for in-hospital mortality
Previous studies utilizing the NHR data in isolated mitral valve surgery, tricuspid valve surgery and combined aortic valve and CABG surgery have shown differences between male and female patients in risk factors and the weights of risk factors for in-hospital mortality (20-22). This demonstrates the presence of differences and the importance to investigate these differences in an aortic surgery population.
The added value of our study is that it allows, due to its national multicenter character with a large sample size and enough events to provide adequate power for a meaningful in-hospital mortality risk factor analysis. In multivariable testing, being female was an independent risk factor for in-hospital mortality. Older age, chronic pulmonary disease, previous cardiac or aortic surgery, and concomitant CAGB and/or valve surgery proved to be independent risk factors. Older age, chronic pulmonary disease, and concomitant mitral valve surgery were also more prevalent in female patients. Regardless of the causative factors underlying the higher observed mortality, we urge clinicians to be aware of these associations.
In this study, we indeed found that the risk factors and weights of the risk factors for in-hospital mortality differ between male and female patients. Beller et al. also found that the relevant risk factors for short-term mortality in ascending aortic aneurysm surgery differed between males and females (e.g., age and myocardial infarction in males, arch involvement and renal insufficiency in females) (6). As the data used in our study was registered patient data, not all possible modifiable risk factors could be included in these analyses, especially aortic diameter at surgery and cardiovascular risk factors such as hypertension and hypercholesterolemia would be valuable to include in the analyses. However, it underlines the importance of further investigating modifiable risk factors to improve personalized clinical care for both male and female patients.
Relevance to patient centered clinical decision making and recommendations
It is likely that there are underlying pathophysiological differences in male and female patients, because comorbidities differ, location of aneurysms differ, and risk factors differ. We recommend more fundamental and translational science to investigate these underlying pathophysiological differences, to aid in (preventive) clinical interventions and decision-making.
Furthermore, investigating the different clinical risk factors for male and female patients is equally important to aid in (preventive) clinical interventions and shared decision-making. Knowledge of specific risk factors can help clinicians to better inform patients of their risks and help patients make an informed decision fitting to their personal values. In this light, we recommend large dedicated multicenter prospective databases specifically set up for patients with thoracic aortic disease, regardless of their treatment trajectory, in order to follow patients over time. Such databases could aid in the further investigation of male-female differences in this specific patient group, including diagnoses, treatment, prognosis, time-to-event data, and include both clinical and non-clinical risk factors (such as aortic diameters before surgery, socio-cultural and economic factors).
Aside from important adverse clinical outcomes, health related quality of life (HRQOL) is an outcome important to the patient undergoing surgery. Prior to surgery, patients with thoracic aortic disease experience a lower health related quality of life, especially the female patients (23). Furthermore, in-depth interviews showed that determinants of HRQOL included physical symptoms, coping strategies, impact on social and professional life, and disease-related knowledge. We recommend clinicians to be aware of these factors influencing HRQOL, to aid in shared decision-making for the individual patient.
Finally, good scientific practice includes the use of standardized terms and definitions. The terms sex and gender are often used interchangeably or incorrectly. We recommend the proper use of these terms (24).
Limitations
This study was a retrospective analysis of registered data. Missing values and mistakes could not be corrected for. Some variables had many missing values, and this should be taken into account when interpreting data, e.g., 12.3% of the study population for whom it was not registered whether they received a supracoronary ascending aorta replacement or an ascending aorta replacement including the aortic root. Valuable information regarding aortic diameter and detailed disease etiology was not present in the registered data.
Conclusions
This nation-wide cohort shows clear male-female differences in patient presentation, procedural characteristics, in-hospital outcomes, and risk factors for mortality in contemporary elective ascending aortic surgery. Further exploration of these male-female differences and of modifiable within-male and within-female risk factors, offers great opportunities in improving treatment and thereby outcomes for both men and women.
Acknowledgments
Funding: This study was supported by
Footnote
Conflicts of Interest: The authors have no conflicts of interest to declare.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Bickerstaff LK, Pairolero PC, Hollier LH, et al. Thoracic aortic aneurysms: a population-based study. Surgery 1982;92:1103-8.
- Clouse WD, Hallett JW Jr, Schaff HV, et al. Improved prognosis of thoracic aortic aneurysms: a population-based study. JAMA 1998;280:1926-9. [Crossref] [PubMed]
- Sampson UK, Norman PE, Fowkes FG, et al. Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010. Glob Heart 2014;9:171-180.e10. [Crossref] [PubMed]
- Pape LA, Awais M, Woznicki EM, et al. Presentation, Diagnosis, and Outcomes of Acute Aortic Dissection: 17-Year Trends From the International Registry of Acute Aortic Dissection. J Am Coll Cardiol 2015;66:350-8. [Crossref] [PubMed]
- Erbel R, Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2873-926. [Crossref] [PubMed]
- Beller CJ, Farag M, Wannaku S, et al. Gender-specific differences in outcome of ascending aortic aneurysm surgery. PLoS One 2015;10:e0124461. [Crossref] [PubMed]
- McMullen H, Yamabe T, Zhao Y, et al. Sex-related difference in outcomes after aortic root replacement. J Card Surg 2020;35:1010-20. [Crossref] [PubMed]
- Preventza O, Cekmecelioglu D, Chatterjee S, et al. Sex Differences in Ascending Aortic and Arch Surgery: A Propensity-Matched Comparison of 1153 Pairs. Ann Thorac Surg 2022;113:1153-8. [Crossref] [PubMed]
- von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453-7. [Crossref] [PubMed]
- Papageorgiou G, Grant SW, Takkenberg JJM, et al. Statistical primer: how to deal with missing data in scientific research? Interact Cardiovasc Thorac Surg 2018;27:153-8. [Crossref] [PubMed]
- Rubin DB. Multiple Imputation for Nonresponse in Surveys. 1 ed. New York, United States of America: John Wiley & Sons, Inc; 1987.
- Friedrich C, Freundt M, Salem MA, et al. Sex-Specific Outcome after Ascending Aortic Surgery in Moderate Hypothermic Circulatory Arrest. Thorac Cardiovasc Surg 2021;69:314-21. [Crossref] [PubMed]
- Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-11. [Crossref] [PubMed]
- Jansen Klomp WW, Brandon Bravo Bruinsma GJ, Peelen LM, et al. Clinical recognition of acute aortic dissections: insights from a large single-centre cohort study. Neth Heart J 2017;25:200-6. [Crossref] [PubMed]
- Boczar KE, Cheung K, Boodhwani M, et al. Sex Differences in Thoracic Aortic Aneurysm Growth. Hypertension 2019;73:190-6. [Crossref] [PubMed]
- Smedberg C, Steuer J, Leander K, et al. Sex differences and temporal trends in aortic dissection: a population-based study of incidence, treatment strategies, and outcome in Swedish patients during 15 years. Eur Heart J 2020;41:2430-8. [Crossref] [PubMed]
- Howard DP, Banerjee A, Fairhead JF, et al. Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study. Circulation 2013;127:2031-7. [Crossref] [PubMed]
- Sokolis DP, Iliopoulos DC. Impaired mechanics and matrix metalloproteinases/inhibitors expression in female ascending thoracic aortic aneurysms. J Mech Behav Biomed Mater 2014;34:154-64. [Crossref] [PubMed]
- Chung J, Stevens LM, Ouzounian M, et al. Sex-Related Differences in Patients Undergoing Thoracic Aortic Surgery. Circulation 2019;139:1177-84. [Crossref] [PubMed]
- Veen KM, Mokhles MM, Braun J, et al. Male-female differences in characteristics and early outcomes of patients undergoing tricuspid valve surgery: a national cohort study in the Netherlands. Eur J Cardiothorac Surg 2019;55:859-66. [Crossref] [PubMed]
- Mokhles MM, Siregar S, Versteegh MI, et al. Male-female differences and survival in patients undergoing isolated mitral valve surgery: a nationwide cohort study in the Netherlands. Eur J Cardiothorac Surg 2016;50:482-7. [Crossref] [PubMed]
- Mokhles MM, Soloukey Tbalvandany S, Siregar S, et al. Male-female differences in aortic valve and combined aortic valve/coronary surgery: a national cohort study in the Netherlands. Open Heart 2018;5:e000868. [Crossref] [PubMed]
- Thijssen CGE, Dekker S, Bons LR, et al. Health-related quality of life and lived experiences in males and females with thoracic aortic disease and their partners. Open Heart 2020;7:e001419. [Crossref] [PubMed]
- Gökalp AL, Thijssen CGE, Roos-Hesselink JW, et al. Dissecting sex and gender. J Thorac Cardiovasc Surg 2020;160:e11. [Crossref] [PubMed]